Diagnosis involves the combination of clinical performance, imaging, laboratory testing, and pathological activation. The platform can help align national and international experts and teams to provide accurate diagnoses and treatment regimens. Individualised treatment regimens for the management of osteoporosis involve the development of treatment regimens, usually including drug therapy, rehabilitation interventions, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of osteoporosis.
The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.